A Study of Nivolumab Safety and Pharmacokinetics in Patients With Severe Sepsis or Septic Shock.
Clinical trial NCT02960854 · COMPLETED
Trial details
- NCT number
- NCT02960854
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-07
- Primary completion
- 2018-01-05
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.